Cell And Gene Therapy Supply Chain/Logistics Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

What industry-specific factors are fueling the growth of the cell and gene therapy supply chain/logistics market?
The escalating demand for cell and gene therapies is propelling the cell and gene therapy supply chain, also known as logistics market, forward. These groundbreaking medical treatments, which involve the modification of cells or genes to combat diseases, offer potential breakthroughs for conditions previously viewed as incurable. However, these therapies necessitate appropriate storage conditions and temperatures, a requirement that can be met through supply chain and logistics services. These services ensure the correct sourcing, distribution, and storage of cell and gene therapies. The American Society of Gene & Cell Therapy, a non-profit scientific and medical organization based in the US, reports a 10% growth in the number of gene therapies in Phase III clinical trials in Q3 2023, marking the first quarterly increase since Q3 2022. Consequently, this heightened demand for cell and gene therapies is fueling the advancement of the cell and gene therapy supply chain or logistics market.

Get Your Cell And Gene Therapy Supply Chain/Logistics Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

What Is the projected market size and growth rate for the cell and gene therapy supply chain/logistics market?
In recent times, there has been rapid expansion in the market size for cell and gene therapy supply chain/logistics. The market which is expected to rise from $1.41 billion in 2024 to about $1.58 billion by 2025 demonstrates a compound annual growth rate (CAGR) of 11.8%. Factors contributing to the growth experienced in the historic period include increased incidence of chronic diseases, effective utilization of supply chain requirements, emphasis on maintaining drug integrity, evolution of regulatory frameworks, and a heightened focus on risk reduction and compliance.

In the coming years, the cell and gene therapy supply chain/logistics market is projected to witness swift expansion. It is estimated to burgeon to $2.44 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 11.5%. The anticipated growth within this forecast period can be credited to factors such as the growth of personalized medicine, advancements in cell-free therapies, the escalating incidence of chronic diseases, expansion of the global cell therapy manufacturing sector, and efficient management of supply chain necessities. Key trends expected during this period include a surge in research and development expenses, the embrace of cutting-edge technologies, facilitative initiatives, and programs for simpler access, collaborations and partnerships among cell and gene therapy entities, supply chain providers, and logistics firms, along with the provision of adaptable services to aid every stage of patient identification.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

What new trends are reshaping the cell and gene therapy supply chain/logistics market and its opportunities?
The increasing prevalence of modern technology platforms in the cell and gene therapy supply chain/logistics market is a significant emerging trend. In order to maintain their competitiveness, leading companies in the space are creating these advanced tech platforms specifically for cell and gene therapies. For example, in April 2023, a healthcare company based in the US known as AmerisourceBergen Corporation, recognized for its specialization in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. This innovative hub is supported by their bespoke customer relationship management (CRM) system. It can be laced with the biopharma platform, thereby enhancing the tracking and delivery of cell and gene therapies.

What major market segments define the scope and growth of the cell and gene therapy supply chain/logistics market?
The cell and gene therapy supply chain/logistics market covered in this report is segmented -

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631

Which region dominates the cell and gene therapy supply chain/logistics market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which key market leaders are driving the cell and gene therapy supply chain/logistics industry growth?
Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

What Is Covered In The Cell And Gene Therapy Supply Chain/Logistics Global Market Report?

• Market Size Forecast: Examine the cell and gene therapy supply chain/logistics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the cell and gene therapy supply chain/logistics market for a structured understanding.
• Key Players Overview: Analyze major players in the cell and gene therapy supply chain/logistics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell and gene therapy supply chain/logistics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the cell and gene therapy supply chain/logistics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell and gene therapy supply chain/logistics market.
• Industry Challenges: Identify potential risks and obstacles affecting the cell and gene therapy supply chain/logistics market.
• Competitive Landscape: Review strategic developments in the cell and gene therapy supply chain/logistics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.